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Abstract 
Objective. To assess body distribution and timing of appearance of rest tremor in Parkinson’s 
disease. 
Methods. Information was obtained by a computerized database containing historical information 
collected at the first visit and data collected during the subsequent follow-up visits. Information on 
rest tremor developed during the follow-up could be therefore obtained by our own observation in a 
proportion of patients. 
Results. Among 289 patients, rest tremor was reported at disease onset in 65.4% of cases and 
detected at last follow-up examination in 74.4% of patients. Analysis of patients who did not report 
rest tremor at disease onset indicated that 26% of such patients (9% in the overall population) 
manifested rest tremor over the disease course. Rest tremor spread to new sites in 39% of patients 
who manifested rest tremor at disease onset. Regardless of tremor presentation at disease onset or 
during the follow-up, upper limb was the most frequent tremor localization. Over the follow-up, 
rest tremor developed faster in the upper limb than in other body sites. The risk of developing rest 
tremor during the follow-up was  not affected by sex, side of motor symptom onset and site of 
tremor presentation. However,  age of disease  onset > 63 years was associated with an increased 
risk of rest tremor spread.  
Conclusions. This study provides new information about body distribution and timing of rest tremor 
appearance during the course of early stages of Parkinson’s disease that may help clinicians in 
patients’ counselling. 
 
1. Introduction 
Tremor in a body part that is completely supported against gravity (rest tremor, RT) is among the 
core diagnostic features of Parkinson’s disease (PD).[1,2] RT is thought to be more prevalent in the 
upper limb (UL) where it can coexist with action tremor (AT).[3, 4]. 
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 Information on the distribution of RT developed in various parts of the body at PD onset and 
during the disease course is limited. We identified only four studies investigating body distribution 
of RT at PD onset. Three of such studies  detected RT in the UL in 42% to 65% of cases and in the 
lower limb (LL) in 3.7% to 24% of cases.[5-7]; one additional study detected  RT in the jaw/lips 
(JL) in < 2% of cases.[8] A further study assessing the distribution of RT in 50 PD patients after 
several years of follow-up confirmed the greater frequency of RT in the UL.[9]  
To our knowledge, no study has systematically compared body distribution of RT at disease 
onset and at follow-up, or provided information about the timing of RT appearance over the disease 
course. In this study, we reviewed the medical records of a large parkinsonian population in order to  
better characterize  the trajectory of tremor across the first years after PD diagnosis.  
 
2. Methods 
Study subjects were recruited among consecutive outpatients attending the movement disorder 
clinic of our department over a 14-month period. The diagnosis of PD was made according to UK 
Parkinson’s Disease Society Brain Bank criteria,[1] and disease was staged according with the 
Hoehn &Yahr (HY) scale.[10] All patients underwent head imaging studies (magnetic resonance 
imaging or computed tomography) as part of their diagnostic work up, and patients with focal brain 
lesions involving the basal ganglia or the brainstem were excluded. Patients with atypical 
parkinsonism, patients with history of recent use of drugs known to induce parkinsonism or to 
induce/enhance tremor, and patients with MiniMental State Examination < 24 were also 
excluded.[11] 
Demographic and clinical information was obtained by a computerized database containing 
historical information collected at the baseline visit and information collected at the subsequent 
follow-up visits. At the first visit,  demographic information, age at first motor symptoms, and 
presence of  RT  at PD presentation were recorded. Whenever possible, patient’s historical report 
obtained at the first visit was supported by an informed relative or records from other physicians, 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 4 
but these supports were not always available. After the first visit, patients were seen every six 
months on average and data about presence and severity of motor signs (assessed by the UPDRS-III 
scale) were recorded. Information on the timing of RT developed during the follow-up could be 
therefore obtained by our own observation in a proportion of patients. RT was examined in the off 
state while patients were in two different positions, i. e. lying down and sitting relaxed in an 
armchair with their hands fully supported by the armrest and feet (without shoes) comfortably 
supported on the floor. The most severe UPDRS-III rating was recorded. AT was defined as a 
tremor that occurred when the body part was required to maintain a posture (postural tremor) or 
perform a movement (kinetic tremor). The levodopa-equivalent daily dose (LEDD) at the last visit 
was calculated as previously reported. [12] Study protocol was approved by the local ethics 
committee. 
Data were expressed as percentage or mean ± SD, and statistical analysis was performed by 
Stata 11.0 package (Stata Corporation, College Station, TX, USA). We used a two-sample t-test to 
determine whether a difference existed between the means of continuous data from the two groups 
of patients  with and without tremor. One-way ANOVA (with Duncan post-hoc test) was instead 
use to test for differences among the mean time interval between disease onset and appearance of 
RT in three populations of patients who manifested tremor in the UL, LL, and JL. Comparison of 
proportions from patients  with and without tremor was performed by Fisher test (two-tailed) or χ2 
test as appropriate. The influence of sex, age at PD onset, and side of motor symptoms presentation 
on the risk of spread of RT to a second body part during the examined disease course was assessed 
by Cox proportional hazard survival analysis. Cox analysis allowed us to simultaneously estimate 
more than one predictor of tremor spread (multivariable analysis) by computing hazard ratio (HR)  
and 95% confidence interval (CI). The relationship between age at PD onset and spread of RT to a 
second body part was also  estimated by Kaplan-Meier survival curves that were compared by 
means of the log-rank test. In both survival techniques, the response variable of interest was the 
amount of time  from PD onset until the occurrence of tremor spread. Patients in whom spread 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 5 
never occurred were included in the survival function for the duration of the observation, and their 
data were censored beyond that time. For all statistical analyses, p values < 0.05 were considered to 
be significant. 
 
3. Results 
Study population included 289 patients with idiopathic PD. There were 173 men and 116 women 
aged 67.5 ± 9.2 (range, 44-84) years. Age at PD onset was 62.5 ± 9.5 (range, 38-83) years.  Patients 
were followed-up for 4.94 ± 3.92 years. At the last follow-up visit, most patients (n. 248) staged < 3 
on the HY scale (mean ± SD, 1.8 ± 0.3) and scored 23.7 + 9.6 (range, 5 – 56) on the UPDRS-III 
scale. Two hundred and sixty-two patients were treated with levodopa, dopamine-agonists, or 
MAO/COMT inhibitors, alone or in  combination [LEDD was 483.4 ± 344.3 mgs (range, 100-
1770)], whereas 27  patients were drug-naïve. No patient had been treated with deep brain 
stimulation. 
 
3.1 Rest tremor at disease onset 
At PD onset, motor symptoms were right-sided in 168 patients, left-sided in 121 patients. One 
hundred out of  289 patients (35%) did not report  tremor at disease onset whereas  189/289 patients 
(65%) reported unilateral RT  (right-sided in 105 patients,  left-sided in 84 patients).  RT  was 
localized in the UL (UL-RT) in 169/189 patients (89.4%), in the LL (LL-RT) in 11/189 patients, 
and in both UL and LL in 9/189 patients, whereas no patient manifested RT in the JL (JL-RT) 
(Figure1). Patients with and without RT at PD onset did not differ for sex (114 men and 75 women 
vs. 59 men and 41 women,  p = 0.82), age of PD onset (62.9 ± 9.6 vs. 61.6  ± 9.2, p = 0.13), and 
side of first symptoms (right-sided, 105/189 vs. 63/100, p = 0.24). 
 
3.2 Rest tremor developed during the follow up 
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Among the 100 patients who did not report tremor on PD onset, 26 (13 men and 13 women aged 
63.2 ± 6.2 years at PD onset) developed RT during the follow-up (Figure. 1). This corresponded to 
9% (26/289) of the whole population. In the group of 26 patients, RT appeared in the more affected 
side and more frequently affected UL than  LL or JL (21/26 vs. 9/26 vs. 1/26 patients; chi-square 
test, p<0.001). The time interval between PD onset and appearance of RT in the 26 patients was 
shorter than the overall follow-up in the 74 patients who did not manifest RT [1.8 ± 1.9 (range, 0.5-
4) vs. 5.4 ± 4.5 (range, 1-12) years, p<0.001). Similar findings were obtained when we  analysed 
10/26 patients in whom tremor was assessed by our own observation [2 ± 2.1 (range, 1-4) vs. 5.4 ± 
4.5 (range, 1-12) years, p=0.01]. In the group of 100 patients, multivariable Cox analysis showed 
that the risk of developing RT during the follow-up was not affected by sex (adjusted HR, 1.58; 
95% CI, 0.65 – 3.82; p = 0.31), age at PD onset (adjusted HR, 1.03; 95% CI, 0.98 – 1.08; p = 0.19), 
and side of motor symptom onset (adjusted HR, 1.56; 95% CI, 0.59 – 3.61; p = 0.41). 
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Fig. 1 Body distribution of rest tremor in the study population at disease onset and on follow-up 
289 patients with Parkinson’s disease
No RT: n. 100 pts. UL-RT: n.169 pts
DISEASE 
ONSET LL-RT: n.11 pts
F
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L
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W
-U
P
RT spread to other
sites in 69 pts **
LL-RT + JL-RT: 
n. 3 pts
Right-sided, n. 2;  
Left-sided, n. 1
RT spread to other
sites in 5 pts ***
UL-RT: n. 5 pts
Right-sided, n.1;  
Left-sided, n. 4
UL-RT+ LL-RT: n.9 pts
RT appeared in 26 pts * No spread 
UL-RT+ LL-RT+ JL-RT: 
n.1 pt
Right-sided, n. 1
tremor was assessed by our own observation in * 10 patients, ** 30 patients, and *** 3 patients
RT = rest tremor;  UL-RT = upper limb rest tremor; LL-RT = lower limb rest tremor; JL-RT = jaw/lip rest tremor
LL-RT: n. 33 pts
Right-sided, n. 18;  
Left-sided, n. 15
JL-RT: n. 15 pts
Contralateral UL-RT:
n. 18 pts
UL-RT: n. 17 pts 
Right-sided, n. 13;  
Left-sided, n. 4
LL-RT: n. 5 pts 
Right-sided, n. 3;  
Left-sided, n. 2
UL-RT + LL-RT: 
n. 3 pts
Right-sided, n. 2;  
Left-sided, n. 1
 
 
 Among the 189 patients who reported RT at PD onset, 74/189 (46 men and 28 women aged 
64.6 ± 8.6 years at PD onset, 39%) manifested spread of RT to additional sites during the follow-up. 
(Figure 1). Spread of RT occurred on the same side of disease onset (n. 41 patients), or followed 
diffusion of PD to the other side (n. 18 patients); in 15 patients tremor spread to the face. The time 
interval between disease onset and spread of RT was shorter than the overall follow-up of the 115 
patients who did not manifest RT spread [3.1 ± 2 (range, 0.5-7) vs. 4.9 ± 4 (range, 1-12) years, 
p<0.001]. Similar findings were obtained when we considered only the 33/74 patients in whom 
tremor was assessed by our own observation [2.9 ± 2.3 (range 0.5-7) vs. 4.9 ± 4 (range, 1-12) years, 
p=0.007).  Multivariable Cox analysis showed that the risk of RT spread to a second body part was 
not affected by sex, side of motor symptom onset and site of tremor presentation (upper limb vs. 
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lower limb); by contrast,  age of PD onset was associated with an increased risk of RT spread 
(Table 1). Stratifying age of PD onset by the median value  (63 years) yielded an increased risk of 
RT spread (adjusted HR, 2.05; 95% CI, 1.25 – 3.67; p = 0.01) in the patients aged 63 years or more 
at  PD onset (Figure 2). 
 
 
 
Figure 2. Kaplan–Meier survival analysis of spread of rest tremor to a second body part: Study time 
was represented by the time elapsed between onset of parkinsonian motor symptoms and spread of 
tremor. Patients in whom spread never occurred were included in the survival function for the 
duration of the observation. The number of at risk patients was 189 at time zero, 60 at 5 yr, and 16 
at 10 yr. 
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 Overall, RT manifested  during the follow-up in 26 + 74 = 100/289 patients (35%) (Figure 
1). When we analysed the time interval between  disease onset and appearance of RT in the 100 
patients, we observed that UL-RT (n. 44 patients) developed faster than LL-RT (n. 45 patients) and 
JL-RT (n. 19 patients): 1.2 ± 1.1 (range, 0.5-4) vs. 3.1 ± 1.9 (range, 2-7) vs. 3.5 ± 2.3 (range, 1-7) 
years (One way ANOVA: F =11.9 , p<0.001; Duncan’s post hoc test: UL-RT group vs. all other 
groups, p<0.05). Similar findings were obtained when we limited analysis to the 43/100 patients (18 
with UL-RT, 21 with LL-RT and 10 with JL-RT) who had RT appearance assessed by our own 
observation [1.3 ± 1.2 (range, 1-3) vs. 3.4 ± 2.6 (range, 2-6) vs. 3.7 ± 1.9 (range, 2-7) years. One 
way ANOVA: F =4.2 , p< 0.05; Duncan’s test: UL-RT group vs. all other groups, p<0.05]. 
 
 
 
Table 1. Results of multivariable Cox regression analysis assessing the risk of spread of rest tremor 
to a second body part by sex, age of onset of parkinsonian motor symptoms, side of motor symptom 
onset, and site of tremor presentation (upper limb vs. lower limb/face). 
 
 
Variable 
 
Hazard ratio 95% confidence interval P 
Women sex 0.72 
 
0.39 – 1.34 0.31 
Age of PD onset (years, 
continuous variable) 
1.04 1.002 – 1.07 0.038 
Right-sided onset of motor 
symptoms 
1.39 0.78 – 2.47 0.26 
Tremor presentation in the upper 
limb 
1.07 0.41 – 2.76  0.88 
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3.3 Rest tremor and other features at the last follow-up visit 
At the last follow-up visit, 215/289 patients (74.4%) manifested RT in the UL (n. 204/215, 94.9%), 
LL (n. 65/215, 30.2%) and JL (n. 19/215, 8.8%). Patients who did not manifest RT on examination 
(n. 74)  had never had RT in the past.  AT in the UL was found in 126/289 (43.4 %) patients (n. 106 
patients with both RT and AT and n. 20 with AT alone). Although we lacked information about the 
number of patients who had AT at PD onset,  we observed AT in 94/178 patients (53%) who 
reported UL-RT at disease onset and in 12/26 patients (46%) who developed RT during the follow-
up ( p = 0.53). 
 Patients with and without RT at the last follow-up visit had similar UPDRS-III motor score 
(23.8 ± 9.9  vs.  23.3 ± 8.8, p = 0.35). Excluding tremor items from UPDRS-III calculation, 
however, yielded  a lower UPDRS-III motor score in patients with RT (21.2 ± 9.2  vs.  23.3 ± 8.8, p 
= 0.044). Duration of disease at the last follow-up visit (4.9 ± 3.8 vs. 5.1 ± 4.2 years, p = 0.35) and 
LEDD (420 ± 358 vs 403 ± 304 mgs, p=0.36) were similar in the two groups.  
 When we analysed UPDRS-III outcome in the 189 patients who presented with RT at PD 
onset we observed that  patients with RT spread reached a  greater UPDRS-III motor score at the 
last follow-up visit than patients who did not spread (26.2 ± 10.4 vs. 21.2 ± 8.9, p = 0.0005). 
However, the difference between groups lacked significance  after excluding tremor items from 
UPDRS-III calculation (21.2 ± 8.4 vs. 19.6 ± 7.9, p = 0.1). Duration of disease at the last 
examination (4.9 ± 4.2 vs. 4.9 ± 3.7 years, p = 1) and LEDD (413 ± 355 vs. 420 ± 373 mgs, p = 
0.45) were similar in the two groups. 
 
 
 
 
 
4. Discussion 
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In this sample,  RT was reported by 65.4% patients at disease onset and detected in 74.4% of 
patients on the last follow-up examination. Analysis of patients who did not report RT at disease 
onset indicated that 26% of such patients (9% in the overall population) manifested RT over the 
disease course. We also observed that RT spread to new sites in 39% of patients who manifested RT 
at disease onset. Regardless of RT presentation at disease onset or during the follow-up, UL was 
the most frequent tremor localization, followed by LL and JL. Over the follow-up, RT developed 
faster in the UL than in other body sites. The risk of developing RT during the follow-up was  not 
affected by sex, side of motor symptom onset and site of tremor presentation. However,  age of PD 
onset > 63 years was associated with an increased risk of RT spread.  
The prevalence figures of RT we observed at disease onset and at the last examination are 
close to those reported by a few published studies. [3, 6-8, 10, 13-15] However, the 9% 
frequency of new cases of RT appearing during the follow-up and the 39% frequency of RT spread 
to new sites are novel findings that can not be compared with any previous data. The validity of 
these estimates is strengthened by the observation that the duration of follow-up in patients who did 
not manifest RT was longer than the time interval between PD onset and appearance of RT. 
The greater occurrence of RT in the UL confirms the findings of previous studies, even 
though the frequency estimate of RT in each body part at disease onset and at the last follow-up 
visit was partly at variance with data from earlier studies (Table 2). Methodological differences 
probably explain discrepancies across studies. For instance, the longer disease duration 
characterizing the studies by Liu [7] and Uitti [8], might have affected the accuracy of tremor self-
report. The greater LL-RT estimates provided by the studies by Gowers [5] and Patrick and Levy 
[6] could be related to the observation that these studies were performed before the advent of 
neuroimaging. It is therefore possible that some patients have been affected by atypical or 
secondary parkinsonisms, conditions that are frequently characterized by tremor in the lower limb 
as initial presenting symptom.[16] Finally, the only one study providing data on the body 
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distribution of RT after several years follow-up was characterized by a small size of the sample, 
which may have reduced the accuracy of the observation.[9] 
 
 
Table 2.  Frequency of occurrence and body distribution of rest tremor in clinical series of patients 
with sporadic Parkinson’s disease. Data is expressed as ratio of number of tremulous patients/total 
number of patients. Percentages are in parenthesis. 
  
DISEASE ONSET 
 
 
FOLLOW-UP 
 
 
 
First author, year 
 
Upper limb  
rest tremor  
 
Lower limb 
rest tremor  
 
Jaw/lip  
rest tremor  
 
Upper limb 
rest tremor  
 
Lower limb 
rest tremor  
 
Jaw/lip  
rest tremor  
Gowers, 1888 41/63  
(65.1%) 
9/63  
(14.3%) 
0 - - - 
Patrick and Levy, 1922 88/146 
(60.3%) 
15/146 
(10.3%) 
0 - - - 
Uitti, 2005  
 
522/1244 
(42%) 
46/1244 
(3.7%) 
21/1244 
(1.7%) 
- - - 
Sternberg, 2013 - - - 20/50 
 (40%) 
6/50   
(12%) 
7/50  
(14%) 
Liu, 2014 
 
80/180  
(44.4%) 
43/180 
(23.9%) 
- - - - 
Present study, 2016 178/289 
(61.6%) 
20/289  
(6.9%) 
0 204/289 
(70.6%) 
65/289 
(22.5%) 
19/289 
(6.6%) 
 
 
 
The predominance and faster development of RT in the UL would suggest that this body 
part is more prone to tremor, or that LL and JL are more resistant to shaking. Owing to a wider 
range of movements, regulatory motor mechanisms are more complex in the UL and might 
therefore be more easily disrupted at a level provoking tremor in the hand than in other sites.[17] 
These considerations also apply to non parkinsonian tremors like essential tremor and dystonic 
tremor. [18, 19] The greater vulnerability of UL to tremor in PD and  in other tremor conditions 
[18,19] raises the possibility of  common pathophysiological mechanisms shared by apparently 
different forms of tremor. This is supported by recent evidence suggesting an involvement of 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 13 
cerebellum in parkinsonian, essential and dystonic tremor, [20-22] and by the observed  
improvement of different types of tremor by surgical procedures targeting the same area.[23, 24] 
We could not find any influence of sex and side of motor symptoms onset on the risk of 
developing RT during the follow-up. However, we observed and increased risk of RT spread to 
further sites in patients aged 63 years of more at PD onset, a novel observation that that can not be 
compared with any previous data.  
Information from UPDRS-III motor score at the last follow-up visit is an agreement with a 
large body of data indicating a lower severity of PD in tremor dominant patients. However, we 
could not find any difference in the severity of non tremor symptoms between patients who 
manifested  spread of RT  and those who did not.  
This study may have limitations. Recall bias could have been a concern in patients who self-
reported RT development. To limit this bias, we recruited patients with early PD and MMSE > 24. 
These criteria were probably responsible for the greater frequency of patients staging < 3 on the HY 
stage and for the relatively short mean duration of follow-up. Therefore, information from our 
sample mainly refers to the early course of PD. Supporting the validity of self-reported data about 
the timing of tremor appearance during the follow-up, findings did not consistently change when we 
separately analyzed 43% of patients who had tremor appearance assessed by our own observation. 
Owing to the retrospective assessment of disease onset, we did not evaluate the possible 
relationships between  severity of parkinsonian symptoms at baseline and spread of tremor. In this 
study, we could not evaluate AT at disease onset because our historical interview focused only on 
the appearance of RT. The close relationship between RT and AT on examination confirmed an 
earlier study from our group indicating that AT usually affects the UL and coexists with RT in a 
proportion of cases.[4] Most patients were on dopaminergic medication, but the well known 
observation that no drug can consistently relieve RT [25], and the similar LEDD observed in the 
group with and without RT  made underestimation of RT occurrence by drug regimen unlikely.  
In conclusion, this study provides new and probably valid information about body 
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distribution and timing of RT development during the early course of PD. Our estimates may help 
clinicians to better counsel PD patients with regard to RT,  one of the core parkinsonian motor signs 
that often can not be consistently relieved by antiparkinsonian therapy. [25] 
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Highlights 
We studied body distribution and time of appearance of rest tremor in a large parkinsonian 
population  
Rest tremor was reported by 65.4% of patients at disease onset  
Rest tremor was described in 74.4% of patients on last follow-up examination  
Rest tremor involved the upper limb more frequently than other body sites  
During the follow-up, rest tremor developed faster in  the upper limb than in other body sites 
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